Because H3K79me2 is deposited exclusively by DOT1L, this major finding also suggests a possible feed-forward loop in leukemias driven by MLL1-DOT1L fusion, which may support combined menin-MLL1 and DOT1L inhibitor therapy. Here, KMT2A is linked to leukemia.